We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$107M
1-Year Est. Return
82.62%
This Fund
S&P 500
This Quarter
Est. Return
+16.29%
1 Year Est. Return
+82.62%
3 Year Est. Return
+219.47%
5 Year Est. Return
+202.9%
10 Year Est. Return
–
AUM
$106M
AUM Growth
+$11.3M
(+12%)
Cap. Flow
+$4.1M
Cap. Flow
% of AUM
3.86%
Top 10 Holdings %
Top 10 Hldgs %
34.45%
Holding
105
New
5
Increased
22
Reduced
41
Closed
8
Top Buys
| 1 |
MDxHealth
MDXH
|
+$1.48M |
| 2 |
BIOL
Biolase, Inc.
BIOL
|
+$1.3M |
| 3 |
AKTS
Akoustis Technologies Inc
AKTS
|
+$1.17M |
| 4 |
EMKR
Emcore Corp
EMKR
|
+$1.02M |
| 5 |
Tactile Systems Technology
TCMD
|
+$724K |
Top Sells
| 1 |
Digi International
DGII
|
+$1.33M |
| 2 |
Achieve Life Sciences
ACHV
|
+$384K |
| 3 |
ASPU
ASPEN GROUP, INC.
ASPU
|
+$302K |
| 4 |
Perion Network
PERI
|
+$279K |
| 5 |
Quest Diagnostics
DGX
|
+$231K |
Sector Composition
| 1 | Healthcare | 57.45% |
| 2 | Technology | 23.08% |
| 3 | Communication Services | 7.64% |
| 4 | Industrials | 5.85% |
| 5 | Consumer Staples | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Idexx Laboratories
IDXX
$44.4B
| $5.4M | 5.09% |
10,805
| – | – |
|
2
Eli Lilly
LLY
$1.05T
| $4.51M | 4.26% |
13,141
-75
| -0.6% | -$25.3K |
|
3
Microsoft
MSFT
$2.93T
| $4.42M | 4.17% |
15,326
| – | – |
|
|
4
Perion Network
PERI
$370M
| $3.89M | 3.66% |
98,185
-8,386
| -8% | -$279K |
|
5
Natera
NTRA
$38.8B
| $3.48M | 3.28% |
62,700
+800
| +1% | +$38.4K |
|
6
NeoGenomics
NEO
$1.9B
| $3.43M | 3.23% |
197,000
-700
| -0.4% | -$9.97K |
|
7
Axogen
AXGN
$2.06B
| $2.92M | 2.76% |
309,490
+2,450
| +0.8% | +$22.4K |
|
|
AUGX
8
DELISTED
Augmedix, Inc. Common Stock
AUGX
| $2.85M | 2.69% |
1,636,843
-43,585
| -3% | -$71.1K |
|
9
Alphatec Holdings
ATEC
$1.32B
| $2.82M | 2.66% |
180,767
-1,950
| -1% | -$27.6K |
|
|
STRM
10
DELISTED
Streamline Health Solutions
STRM
| $2.81M | 2.65% |
104,023
-72
| -0.1% | -$2.04K |
|
11
Veracyte
VCYT
$4.68B
| $2.72M | 2.56% |
121,880
-1,150
| -0.9% | -$27.8K |
|
12
Abbott
ABT
$173B
| $2.67M | 2.52% |
26,380
-100
| -0.4% | -$10.6K |
|
13
Advanced Micro Devices
AMD
$816B
| $2.49M | 2.35% |
25,434
-250
| -1% | -$20.3K |
|
|
14
Digi International
DGII
$2.41B
| $2.35M | 2.22% |
69,883
-39,000
| -36% | -$1.33M |
|
15
Pfizer
PFE
$143B
| $2.01M | 1.9% |
49,341
-1,075
| -2% | -$46.4K |
|
16
LeMaitre Vascular
LMAT
$2.31B
| $1.88M | 1.77% |
36,436
-1,150
| -3% | -$55.8K |
|
17
AbbVie
ABBV
$451B
| $1.83M | 1.73% |
11,508
-100
| -0.9% | -$15.3K |
|
18
Ooma
OOMA
$568M
| $1.83M | 1.73% |
146,400
+1,000
| +0.7% | +$13.4K |
|
19
TELA Bio
TELA
$36.3M
| $1.77M | 1.67% |
166,500
-6,750
| -4% | -$74.5K |
|
20
Perspective Therapeutics
CATX
$340M
| $1.75M | 1.65% |
274,964
-2,300
| -0.8% | -$9.39K |
|
|
PFIE
21
DELISTED
Profire Energy, Inc
PFIE
| $1.74M | 1.64% |
1,404,216
-25,614
| -2% | -$29.6K |
|
22
General Mills
GIS
$20.2B
| $1.69M | 1.6% |
19,825
-500
| -2% | -$39.9K |
|
|
AKTS
23
DELISTED
Akoustis Technologies Inc
AKTS
| $1.69M | 1.6% |
549,250
+334,900
| +156% | +$1.17M |
|
24
Inuvo
INUV
$20.9M
| $1.64M | 1.55% |
563,108
-1,200
| -0.2% | -$4.21K |
|
25
SkyWater Technology
SKYT
$1.55B
| $1.59M | 1.5% |
140,000
| – | – |
|
Similar funds
EWL
ECM
HCA
CWM
SNPAM
TWM
ACL
FMI
Perkins Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Perkins Capital Management held 105 positions worth $106M, up 12% from $94.7M the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Perkins Capital Management deployed $4.1M of net new capital in Q1 2023, opening 5 new positions and adding to 22 existing holdings. Its largest new stake was Emcore Corp: 83,600 shares worth $961K.
By sector, the portfolio is most concentrated in Healthcare at 57% of assets, up from 57% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Digi International, an estimated $1.33M trimmed.
- Perkins Capital Management's largest Q1 2023 buy was Emcore Corp: 83,600 shares worth $961K.
- Perkins Capital Management added most to MDxHealth in Q1 2023, an estimated $1.48M increase.
- Perkins Capital Management's biggest Q1 2023 reduction was Digi International, cutting an estimated $1.33M.
- Perkins Capital Management fully exited ASPEN GROUP, INC. in Q1 2023, selling an estimated $302K.
- Perkins Capital Management's ten largest holdings make up 34% of its $106M portfolio in Q1 2023.
- Perkins Capital Management opened 5 new positions and closed 8 in Q1 2023.
- Perkins Capital Management's portfolio value rose 12% quarter-over-quarter to $106M.
Based on Perkins Capital Management's 13F filing for Q1 2023, filed 9 May 2023.